About us

About us

Al Kindi Company

Production of vaccines and veterinary medicines

We are a leading company since 1991, specializing in the development and production of vaccines and Veterinary Medicines. We are committed to protecting animal health and public health by controlling common diseases and providing safe and effective solutions to address diseases affecting livestock. Our goal is to support individuals and communities by enhancing health security and ensuring the sustainability of the livestock sector.

Our Ambition

To meet the internal demand of both the private and public sectors for vaccines and veterinary medicines and to support the national economy necessary to protect livestock from diseases and epidemics and to protect public health from zoonotic diseases, our company produces viral and bacterial vaccines as well as medicines against viral and bacterial diseases and vitamins that support animal immunity. Testing and examinations on animals are conducted before the product is released by the quality control department in the company to ensure the safety of the product and its marketing. All company products are registered with the Veterinary Directorate, and some products have been tested in prestigious international laboratories such as the Cirad laboratory in France.

Establishment Company

Al-Kindi Company was established in a small laboratory founded in 1924 to diagnose animal diseases and conduct research for vaccine production. In 1934, it was named the “Laboratory and Veterinary Serums Department” and worked on producing vaccines for sheep pox, hemorrhagic septicemia, anthrax, and blackleg.

The laboratory expanded with advancements in scientific and technical research to fulfill its role in protecting livestock. The current location in Abu Ghraib was selected in 1961 to conduct disease surveys and produce various veterinary vaccines according to the approved scientific and technical specifications.

On January 10, 1990, Al-Kindi Company for the production of vaccines and veterinary medicines was established under the Industrial Law.

Our Goals

A number of veterinarians with primary and advanced degrees, as well as scientific research assistants, middle staff, technical workers, and administrative and accounting personnel currently work at the company.

The company aims to produce effective and safe vaccines and veterinary medicines to meet the internal demand of both the public and private sectors. It also strives to conduct research and studies, exchange expertise with specialized scientific bodies inside and outside Iraq, contribute to certain research projects, and support the training of company staff. Additionally, the company sends medical and technical staff to the People’s Republic of China for training on imported equipment to develop vaccine production and control diseases and epidemics. Among its goals is also the pursuit of contractual relationships with various Arab and foreign entities to export the company’s products.

Our Vision

We aspire to be one of the leading global companies in the production of vaccines and veterinary medicines, with a steadfast commitment to continuous innovation and high quality in all our products. We aim to expand our operations and enter new markets to meet the growing needs of the veterinary sector and support animal health at globally competitive levels.

Our Message

We are committed to enhancing the public health of livestock by providing effective and safe vaccines that contribute to the prevention and control of diseases. We strive to achieve the health sustainability of livestock, supporting food security and contributing to the development of this vital sector at global levels.

Company Development

In order to develop the company’s production and keep up with global advancements in vaccine production, the company obtained the Quality Management Certificate (ISO 9001:2015) in 2017. It imported some supportive equipment for the production process and raw materials from reputable companies to accelerate production and facilitate the production work. Among the most important are:

  • Raw materials and culture media.
  • Modern cabinet number ( ).
  • Special incubator for viral vaccines 37°C (CO2) number (2).
  • An advanced microscope that helped improve the accuracy of examinations in quality control and production departments.
  • Autoclave with boiler, number (2), specifically for bacterial vaccines, with a production capacity of 50 flasks per 60 minutes compared to the old equipment with a production capacity of 20 flasks per 60 minutes.
  • Importing vaccine filling bottles of various sizes from reputable origins for vaccine filling.
  • Freeze-drying device for viral vaccines: the company previously had a freeze-drying device with a production capacity of 6,500 vials in 48 hours. Two new devices were imported with a production capacity of 22,400 vials in 16 hours.
  • Vial capping device: Previously, the capping of bottles used for vaccine filling was done manually and took time. The imported device has a production capacity of 22,400 vials in 3 hours.
  • Labeling device: Previously, the labels were applied manually, which was not ideal. Two new devices were imported with a production capacity of 22,400 vials in 6 hours.
  • Enhancing the production, quality control, and commercial departments with large freezers to store strains and semi-manufactured and manufactured vaccines, as well as creating cold rooms to store bacterial vaccines.

These devices and raw materials contributed to the rapid production of bacterial and viral vaccines and increased the designed and available capacities. However, due to the lack of direct supply to the Veterinary Directorate and competition with imported prices, there was a decrease in the execution capacity for vaccines.